 |
|
|
| |
Telaprevir in the Treatment of Acute HCV in HIV-infected Men
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Daniel S. Fierer, Douglas Dieterich, Michael Mullen, Andrea Branch, Alison Uriel, Damaris Carriero, Wouter van Seggelen, Rosanne Hijdra, David Cassagnol, and the New York Acute HCV Surveillance Network
the authors characterized 9 patients with "relapse/reinfection"-
ID Week: Acute HCV Treatment/HIV+ MSM/HCV Screening/New HCV Therapies: "Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus" - (10/16/13)
EACS: Substantial rates of Acute Hepatitis C Reinfection in European HIV-positive Patients - (10/21/13)
from Jules: the risk for reinfection in MSM & IDUs is not a good reason for not providing treatment, it is an opportunity to provide education to prevent reinfection.
-----------------------
|
| |
|
|
|
|
|
